Recurrent Achromobacter piechaudii Bacteremia in a Patient with Hematological Malignancy
نویسندگان
چکیده
منابع مشابه
Recurrent Achromobacter piechaudii bacteremia in a patient with hematological malignancy.
We describe a recurrent bacteremia caused by Achromobacter (formerly Alcaligenes) piechaudii in association with an intravenous catheter in an immunocompromised 73-year-old man. This is the first reported case of bacteremia due to A. piechaudii.
متن کاملTrichosporon asahii fungemia in a patient with non-hematological malignancy.
Trichosporon fungemia is usually seen in neutropenic patients with underlying hematological malignancies. In this report we describe a fatal case of Trichosporon asahii fungemia in a non-neutropenic patient with a non-hematological malignancy. For 1 week the patient exhibited hematuria, weakness, easy fatigability and headaches. At admission she had anemia, renal failure and evidence of right h...
متن کاملAchromobacter piechaudii bloodstream infection in an immunocompetent host
BACKGROUND Achromobacter piechaudii is a rare cause of clinical disease in humans. Previously, clinical disease has only been documented in immunocompromised patients. We present a case of Achromobacter piechaudii bacteremia in a patient with previous malignancy but no known immunosuppression. CASE REPORT A 67-year-old man with distant history of colon and prostate cancer presented with low g...
متن کاملParvimonasmicra bacteremia in a patient with colonic carcinoma
Background: Parvimonas micra is a gram-positive anaerobe and a part of the normal commensal flora of the gastrointestinal tract. Factors predisposing to anaerobic bacteremia include malignant neoplasms, periodontal disease, immune deficiencies, chronic renal insufficiency, decubitus ulcers and perforated abdominal viscus. Cases of Parvimonas bacteremia in a patient with esophageal carcinoma and...
متن کاملRecurrent Campylobacter jejuni bacteremia in a patient with hypogammaglobulinemia
RATIONALE Although some cases of recurrent bacteremia due to Campylobacter jejuni have been reported in immunocompromised patients, antibiotic treatment strategies to eradicate C. jejuni and prevent recurrent infections in immunocompromised patients have not been established. Authors' experience of such rare cases should be shared for improving patients' outcomes. PATIENT CONCERNS An 18-year-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Microbiology
سال: 2001
ISSN: 0095-1137,1098-660X
DOI: 10.1128/jcm.39.2.808-810.2001